Nanjing Well Pharmaceutical Co Ltd (603351) — Strategic Asset Allocation Index
Nanjing Well Pharmaceutical Co Ltd (603351) has a Strategic Asset Allocation Index of 99.4% as of June 2023. Strategic assets (PP&E of CN¥1.51 Billion plus long-term investments of CN¥-) total CN¥1.51 Billion, measured against net assets of CN¥1.52 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 603351 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Nanjing Well Pharmaceutical Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Nanjing Well Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 99.4%, representing strategic assets of CN¥1.51 Billion against net assets of CN¥1.52 Billion CNY. See 603351 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Nanjing Well Pharmaceutical Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing Well Pharmaceutical Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Nanjing Well Pharmaceutical Co Ltd.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 100.0% | CN¥1.48 Billion | CN¥1.48 Billion | CN¥- | CN¥1.48 Billion | ▲ +12.5 pp |
| 2021 | 87.5% | CN¥1.21 Billion | CN¥1.21 Billion | CN¥- | CN¥1.39 Billion | ▲ +15.1 pp |
| 2020 | 72.4% | CN¥940.80 Million | CN¥940.80 Million | CN¥- | CN¥1.30 Billion | ▲ +32.1 pp |
| 2019 | 40.3% | CN¥500.65 Million | CN¥500.65 Million | CN¥- | CN¥1.24 Billion | ▼ -19.8 pp |
| 2018 | 60.1% | CN¥369.32 Million | CN¥369.32 Million | CN¥- | CN¥614.61 Million | ▲ +2.8 pp |
| 2017 | 57.3% | CN¥305.30 Million | CN¥305.30 Million | CN¥- | CN¥532.80 Million | ▲ +4.4 pp |
| 2016 | 52.9% | CN¥234.80 Million | CN¥234.80 Million | CN¥- | CN¥443.99 Million | — |